Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06163898 |
| Title | A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Celgene |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Local Institution - 0033 | Birmingham | Alabama | 35294 | United States | Details | |
| Local Institution - 0035 | New Haven | Connecticut | 06511 | United States | Details | |
| Local Institution - 0018 | New York | New York | 10065 | United States | Details | |
| Local Institution - 0021 | Petah-Tikva | HaMerkaz | 4910021 | Israel | Details | |
| Local Institution - 0030 | Ramat Gan | HaMerkaz | 5262100 | Israel | Details | |
| Local Institution - 0020 | Jerusalem | 9112001 | Israel | Details |